STEPHANIE BEASLEY: Open Payments
NPI 1073820338 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 31 payments from 10 companies in 2025. Trend: 2023 $377 · 2024 $391 · 2025 $808
Food & beverage: $708Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $172 |
| Janssen Biotech, Inc. | 5 | $159 |
| GENZYME CORPORATION | 1 | $145 |
| ABBVIE INC. | 9 | $135 |
| Incyte Corporation | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Amgen Inc. | 2 | $30 |
| LEO Pharma Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, OPZELURA, COSENTYX, Otezla, ANZUPGO, TALTZ.
Industry payments across MS — which companies pay providers there.
